{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Class (Stereo):
CHEMICAL (RACEMIC)
Alepride is a sulpiride derivative. It is an antiemetic agent.
Status:
Investigational
Source:
NCT00730405: Phase 2 Interventional Completed Onychomycosis
(2008)
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Albaconazole is a triazole antifungal. Azoles are important antifungal compounds, and all drugs in this class inhibit ergosterol synthesis by blocking the 14-α-demethylase enzyme, resulting in the accumulation of toxic methylsterols that may culminate in fungal death. Albaconazole, an oral agent that has demonstrated high levels of bioavailability and potent antifungal activity. It was under development for the treatment of onychomycosis, vulvovaginal candidiasis. Also, albaconazole was evaluated in phase I, a randomized, placebo-controlled clinical trial in patients with tinea pedis. No serious adverse effects occurred in the studies involving albaconazole. However, this researches on this drug were discontinued.
Status:
Investigational
Source:
NCT02179814: Not Applicable Interventional Suspended Bulimia Nervosa
(2012)
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
Conditions:
Racemetirosine is an orally active inhibitor of the enzyme tyrosine 3-monooxygenase, and consequently of the synthesis of catecholamine. At dosages of 600 to 3500mg daily, it is effective in controlling the hypertensive episodes and symptoms of catecholamine excess in phaeochromocytoma during preparation for surgery. Oral Racemetirosine is well absorbed and absorption appears constant in each individual over a wide dosage range. The drug is largely excreted via the kidneys, but extrarenal elimination has not been studied. Case reports on the clinical use of Racemetirosine in phaeochromocytoma indicate that the drug controls hypertension and symptoms of catecholamine excess in most patients during preparation for surgical removal of a tumor. In some cases, the addition of Racemetirosine to phenoxybenzamine plus propranolol has resulted in adequate control of symptoms previously unresponsive to the adrenergic blocking regimen. Drowsiness and sedation have been the most frequently reported side effects of Racemetirosine treatment.
Status:
Class (Stereo):
CHEMICAL (ACHIRAL)
Prodeconium Bromide is a Decamethylene derivative with neuromuscular blocking activity. Prodeconium Bromide acts as a muscle relaxant of short action and belongs to the group of mixed blocking agents. Its complete effect in man is obtained in 100 sec. and lasts for 7 min. Respiratory paralysis is produced by 1 mg/kg of Prodeconium
Status:
Investigational
Source:
INN:potassium nitrazepate [INN]
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Nitrazepate is the diazepam derivative. Nitrazepate is tranquiliser.
Status:
Investigational
Class (Stereo):
CHEMICAL (ABSOLUTE)
Class (Stereo):
CHEMICAL (MIXED)
Pranosal is the analgesic and anti-inflammatory agent. It has been used as the salicylate as a topical analgesic in concentrations of 5% in rheumatic and other disorders.
Status:
Investigational
Class (Stereo):
CHEMICAL (ACHIRAL)
Simtrazene (centrazene) is an anti-neoplastic compound which is not an alkylating agent. Centrazene was more effective than thioTEPA in prolonging the life span of mice bearing C3H mammary tumors but did not demonstrate activity against other tumor types.
Status:
Class (Stereo):
CHEMICAL (ACHIRAL)
Hydroxyprocaine was invented as a local anesthetic drug that possessed the antibacterial properties. Information about the current use of this drug is not available.
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Ambasilide, a class III antiarrhythmic, has been shown to block multiple cardiac channels in a variety of animals including humans. Ambasilide is a potassium channel antagonist. Ambasilide has multichannel blocking properties including beta-adrenergic antagonism.